Get the Stockscreener App
184.52
2.30%
-4.35
After Hours:
184.52
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ligand Pharmaceuticals Inc stock is traded at $184.52, with a volume of 172.74K.
It is down -2.30% in the last 24 hours and up +6.58% over the past month.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
See More
Previous Close:
$188.87
Open:
$187.8
24h Volume:
172.74K
Relative Volume:
0.78
Market Cap:
$3.62B
Revenue:
$152.42M
Net Income/Loss:
$45.24M
P/E Ratio:
73.51
EPS:
2.51
Net Cash Flow:
$6.97M
1W Performance:
-0.57%
1M Performance:
+6.58%
6M Performance:
+65.67%
1Y Performance:
+59.72%
1-Day Range:
$182.87
$191.88
1-Week Range:
$182.87
$194.44
52-Week Range:
$93.58
$194.44
Ligand Pharmaceuticals Inc Stock (LGND) Company Profile
Name
Ligand Pharmaceuticals Inc
Sector
Industry
Phone
858-550-7500
Address
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
Compare LGND with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LGND
Ligand Pharmaceuticals Inc
|
184.52 | 3.68B | 152.42M | 45.24M | 6.97M | 2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.21 | 108.30B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
652.91 | 69.37B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.59 | 62.38B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
821.97 | 51.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.95 | 34.94B | 398.11M | -1.03B | -868.57M | -5.7032 |
Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Stifel | Buy |
| Oct-03-24 | Initiated | Oppenheimer | Outperform |
| Jul-30-24 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-21 | Resumed | Stephens | Overweight |
| Feb-04-21 | Reiterated | H.C. Wainwright | Buy |
| Oct-06-20 | Initiated | Barclays | Overweight |
| Mar-24-20 | Downgrade | Argus | Buy → Hold |
| Mar-10-20 | Initiated | Guggenheim | Neutral |
| Feb-06-20 | Initiated | The Benchmark Company | Buy |
| Sep-19-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-11-19 | Initiated | Barclays | Equal Weight |
| May-03-19 | Reiterated | H.C. Wainwright | Buy |
| Mar-06-19 | Reiterated | H.C. Wainwright | Buy |
| Oct-29-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-11-18 | Reiterated | Argus | Buy |
| Aug-17-18 | Initiated | Goldman | Neutral |
| Aug-08-18 | Downgrade | ROTH Capital | Buy → Neutral |
| Jun-21-18 | Initiated | Argus | Buy |
| Dec-27-17 | Reiterated | H.C. Wainwright | Buy |
| Sep-05-17 | Resumed | H.C. Wainwright | Buy |
| Oct-05-16 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-16 | Downgrade | Deutsche Bank | Hold → Sell |
| Mar-11-16 | Initiated | Sidoti | Buy |
| Mar-03-16 | Initiated | H.C. Wainwright | Buy |
View All
Ligand Pharmaceuticals Inc Stock (LGND) Latest News
Ligand Pharmaceuticals Reaches Analyst Target Price - Nasdaq
Is Ligand Pharmaceuticals Incorporated (LGDN) stock attractive post correctionStock Surge & Free High Accuracy Swing Entry Alerts - newser.com
What institutional flow reveals about Ligand Pharmaceuticals IncorporatedWeekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - newser.com
Intraday pattern recognizer results for Ligand Pharmaceuticals IncorporatedJuly 2025 Outlook & Daily Momentum Trading Reports - newser.com
Short interest data insights for Ligand Pharmaceuticals Incorporated2025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - newser.com
What catalysts could drive Ligand Pharmaceuticals Incorporated stock higherPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com
Can Ligand Pharmaceuticals Incorporated stock sustain market leadership2025 Market Overview & Weekly High Return Opportunities - newser.com
What analyst consensus says on Ligand Pharmaceuticals Incorporated stockWeekly Risk Summary & Free Daily Entry Point Trade Alerts - newser.com
Can technical indicators confirm Ligand Pharmaceuticals Incorporated’s reversalQuarterly Market Review & Community Consensus Trade Signals - newser.com
Why Ligand Pharmaceuticals Incorporated stock is a value investor pickJuly 2025 Chart Watch & Real-Time Stock Entry Alerts - Fundação Cultural do Pará
How to use Fibonacci retracement on Ligand Pharmaceuticals IncorporatedQuarterly Profit Review & Verified Momentum Watchlists - newser.com
Technical signs of recovery in Ligand Pharmaceuticals IncorporatedPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Is Ligand Pharmaceuticals Incorporated reversing from oversold territoryStop Loss & Intraday High Probability Setup Alerts - newser.com
Does Ligand Pharmaceuticals Incorporated show high probability of reboundJuly 2025 Review & Weekly High Potential Alerts - newser.com
Published on: 2025-10-28 01:03:19 - newser.com
How Ligand Pharmaceuticals Incorporated (LGDN) stock compares with market leadersCPI Data & Daily Oversold Bounce Ideas - newser.com
Analyzing drawdowns of Ligand Pharmaceuticals Incorporated with statistical tools2025 Macro Impact & Low Risk Entry Point Tips - newser.com
Ligand Pharmaceuticals Incorporated stock daily chart insightsWeekly Profit Report & Community Driven Trade Alerts - newser.com
Will Ligand Pharmaceuticals Incorporated outperform the market2025 Trading Recap & Risk Controlled Swing Alerts - newser.com
Price action breakdown for Ligand Pharmaceuticals IncorporatedJuly 2025 Summary & Daily Stock Trend Reports - newser.com
Is Ligand Pharmaceuticals Incorporated forming a reversal patternPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Chart overlay techniques for tracking Ligand Pharmaceuticals IncorporatedWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com
Is Ligand Pharmaceuticals Incorporated a good long term investmentRetail Trading Trends & Beat the Market with AI Reports - earlytimes.in
Published on: 2025-10-26 22:30:09 - newser.com
Ligand Pharmaceuticals Inc Stock (LGND) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):